AUROBINDO PHARMA LTDShort
Auropharma Tech. Analysis
Updated
Since many days Auropharma is in a uptrend but on 23 june and 24 june a pattern was formed known as
dark cloud covering from that pattern formation it made a low of 775 from the high of 819. and it also broke the support uptrend line with heavy volumes.
Not only this but since the starting of the uptrend on 4 may to 24 june the MACD was also showing the Negative Diversion and on 26 june we got an confirmation of three things 1) MACD 2) Dark Cloud Covering 3) Breaking of the line of Uptrend.
My view of the Auropharma is of shorting.
Support 760, 730, 710, 685.
Resistance 785, 792, 797, 805.
**I AM NOT SEBI REGISTERED ANALYSIST THIS IS MY PERSONAL VIEW RELATED TO AUROPHARMA**
dark cloud covering from that pattern formation it made a low of 775 from the high of 819. and it also broke the support uptrend line with heavy volumes.
Not only this but since the starting of the uptrend on 4 may to 24 june the MACD was also showing the Negative Diversion and on 26 june we got an confirmation of three things 1) MACD 2) Dark Cloud Covering 3) Breaking of the line of Uptrend.
My view of the Auropharma is of shorting.
Support 760, 730, 710, 685.
Resistance 785, 792, 797, 805.
**I AM NOT SEBI REGISTERED ANALYSIST THIS IS MY PERSONAL VIEW RELATED TO AUROPHARMA**
Trade closed: target reached
SO GUYS AS I TOLD YESTERDAY THAT MARKET WILL FACE RESISTANCE AT THE RATE OF 785, 792, 797, 805. AND ACTUALLY THIS STOCK MADE A HIGH OF 797.95 .ON THE OTHER HAND THE RATE OF SUPPORT WERE 760, 730, 710, 685. AND AUROPHARMA MADE A LOW OF 779 WHICH IS NEAR TO 760.
YOU CAN SUGGEST YOUR STOCKS TOO, SO THAT I CAN ANALYSIS AND CAN SHARE WITH YOU..
THANKYOU.
** I AM NOT SEBI REGESTERED ANALYSIST ALL THIS I SHARE MY PERSONAL OPINION.**
Note
SO GUYS FROM THE DAY OF SHORT I TOLD 28 JUNE TO 30 JUNE AUROPHARMA HAS FALLEN UP TO 9 TO 12 POINTS... ** I AM NOT SEBI REGESTRED ANALYSIST I JUST SHARE MY PERSONAL VIEW AND OPINION .**
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.